These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24510061)

  • 1. Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab.
    Scarpioni R; Rigante D; Cantarini L; Ricardi M; Albertazzi V; Melfa L; Lazzaro A
    Clin Rheumatol; 2015 Jul; 34(7):1311-6. PubMed ID: 24510061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation.
    Itamiya T; Komai T; Kanda H; Nagafuchi Y; Chang H; Shibata S; Ishiura H; Shoda H; Toda T; Fujio K
    Clin Rheumatol; 2022 Jul; 41(7):2233-2237. PubMed ID: 35314925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
    Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM
    Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens.
    Kuemmerle-Deschner JB; Wittkowski H; Tyrrell PN; Koetter I; Lohse P; Ummenhofer K; Reess F; Hansmann S; Koitschev A; Deuter C; Bialkowski A; Foell D; Benseler SM
    Arthritis Res Ther; 2013; 15(3):R64. PubMed ID: 23718630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal amyloidosis revealing a cryopyrin associated periodic syndrome].
    Robinet G; Renaudineau E; Lamaison C; Cam G; Rioux-Leclercq N
    Ann Pathol; 2018 Dec; 38(6):401-406. PubMed ID: 30236822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).
    Kuemmerle-Deschner JB; Ramos E; Blank N; Roesler J; Felix SD; Jung T; Stricker K; Chakraborty A; Tannenbaum S; Wright AM; Rordorf C
    Arthritis Res Ther; 2011 Feb; 13(1):R34. PubMed ID: 21356079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.
    Wittkowski H; Kuemmerle-Deschner JB; Austermann J; Holzinger D; Goldbach-Mansky R; Gramlich K; Lohse P; Jung T; Roth J; Benseler SM; Foell D
    Ann Rheum Dis; 2011 Dec; 70(12):2075-2081. PubMed ID: 21908452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
    Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S
    Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab].
    Yokota S; Kikuchi M; Nozawa T; Kizawa T; Kanetaka T; Miyamae T; Mori MA; Nishikomori R; Takata H; Heike T; Hara T; Imagawa T
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):23-9. PubMed ID: 22374439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
    Topaloglu R; Batu ED; Orhan D; Ozen S; Besbas N
    Pediatr Nephrol; 2016 Apr; 31(4):633-40. PubMed ID: 26563115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review.
    Rodrigues F; Cuisset L; Cador-Rousseau B; Giurgea I; Neven B; Buob D; Quartier P; Hachulla E; Lequerré T; Cam G; Boursier G; Hervieu V; Grateau G; Georgin-Lavialle S
    Rheumatology (Oxford); 2022 Nov; 61(12):4827-4834. PubMed ID: 35262642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Clinical Case of Cryopyrin-associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report.
    Zayaeva AA; Sokolova LV; Shaduro DV; Petrov AV; Kulanthaivel S; Kaliberdenko VB
    Curr Rheumatol Rev; 2022; 18(4):373-379. PubMed ID: 34784874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic fever: From Still's disease to Muckle-Wells syndrome.
    Solís Marquínez MN; García Fernández E; Morís de la Tassa J
    Reumatol Clin (Engl Ed); 2019; 15(5):e39-e40. PubMed ID: 28583784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult patient diagnosed with Muckle-Wells syndrome, antiphospholipid syndrome and glomerular haematuria.
    Blokland SL; Limper M; van Eerde AM; Remmelts HH
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38191227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muckle-Wells syndrome: clinical perspectives.
    Tran TA
    Open Access Rheumatol; 2017; 9():123-129. PubMed ID: 28744167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muckle-Wells Syndrome Across Four Generations in One Czech Family: Natural Course of the Disease.
    Fingerhutová Š; Fráňová J; Hlaváčková E; Jančová E; Procházková L; Beránková K; Tesařová M; Honsová E; Doležalová P
    Front Immunol; 2019; 10():802. PubMed ID: 31057541
    [No Abstract]   [Full Text] [Related]  

  • 19. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.
    Russo RA; Melo-Gomes S; Lachmann HJ; Wynne K; Rajput K; Eleftheriou D; Edelsten C; Hawkins PN; Brogan PA
    Rheumatology (Oxford); 2014 Apr; 53(4):665-70. PubMed ID: 24352339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.